We develop CTC-based tests to monitor cancer
What are CTC?
Circulating Tumor Cells (CTC) are major cellular agents directly responsible for cancer spreading. From the earliest stages of cancer development, CTC are shed by the primary tumor and circulate through the bloodstream. The dissemination of CTC plays a critical role in rising secondary tumors in distant organs.
The follow-up of CTC rates is a powerful biomarker of cancer progression.
High levels of CTC are associated with
- Cancer aggressiveness
- Metastasis development
- Resistance to treatments
- Cancer relapse
How can CTC detection in blood help cancer monitoring?
As CTC reflect dynamic changes in tumors overtime, their reliable detection from clinical samples can serve as an effective tool for cancer monitoring.
Using simple blood draws at regular intervals, Oncosema technology gives timely and sensitive insights into cancer development from its early stages, with many future clinical applications
- Initial prognosis reflecting cancer aggressiveness at cellular levels
- Diagnosis confirmation of cancers difficult to detect
- Timely assessment of treatment efficacy
- Early detection of cancer relapse